Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

California ,United States ,Rock Springs ,South San Francisco ,Mike Nolan ,Ellen Hukkelhoven ,Peter Kolchinsky ,Prnewswire Freenome ,Kaiser Permanente ,Bain Capital Life Sciences ,Research Company ,Life Sciences Growth Fund ,American Cancer Society Brightedge Ventures ,Novartis ,Eventide Asset Management ,T Rowe Price Associates Inc ,Freenome Holdings Inc ,United States Preventive Services Task Force ,Roche Venture Fund ,Perceptive Advisors ,American Cancer Society ,Brightedge Ventures ,Artis Ventures ,Catalio Capital Management ,Cormorant Capital ,Farallon Capital Management ,Fidelity Management ,Janus Henderson Investors ,Polaris Partners ,Ridgeback Capital Management ,Rock Springs Capital ,Sands Capital ,Soleus Capital Management ,Price Associates ,Arrowmark Partners ,Byers Capital ,Intermountain Ventures ,Logos Capital ,Pura Vida Investments ,Suvretta Capital Management ,Colorectal Cancer Screening Test Use ,Mortal Wkly Rep ,States Preventive Services Task Force ,Science ,Business ,Health ,Pr Newswire ,Philanthropy ,Cancer ,